Overview

Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia

Status:
Not yet recruiting
Trial end date:
2025-12-15
Target enrollment:
Participant gender:
Summary
Clinical trial to assess the efficacy of Vortioxetine compared with treatment as usual in early schizophrenia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Treatments:
Antipsychotic Agents
Vortioxetine